Maria Carrillo
Maria Carrillo is the Chief Science Officer of the Alzheimer's Association, where she plays a pivotal role in advancing research and awareness about Alzheimer’s disease. Her expert insights on biomarkers, particularly p-tau217, are instrumental in understanding the diagnosis and progression of Alzheimer’s, contributing to the development of innovative testing methods that aim to improve early detection and treatment.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| United States | 1 | 8.00 | 0.02% | +0% | 331,002,651 | 72,748 | $21,000,000 | 4,615$ |
| Totals | 1 | 331,002,651 | 72,748 | $21,000,000 | 4,615$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United States:
Dr. Maria Carrillo is the chief science officer of the Alzheimer’s Association and has commented on the effectiveness of p-tau217 as a biomarker for Alzheimer’s.
8